Literature DB >> 23677008

Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis.

Lionel Rigottier-Gois1.   

Abstract

The healthy intestine is characterized by a low level of oxygen and by the presence of large bacterial communities of obligate anaerobes. Dysbiosis of the gut microbiota has been reported in patients suffering from inflammatory bowel diseases (IBDs), but the mechanisms causing this imbalance remain unknown. Observations have included a decrease in obligate anaerobes of the phylum Firmicutes and an increase in facultative anaerobes, including members of the family Enterobacteriaceae. The shift of bacterial communities from obligate to facultative anaerobes strongly suggests a disruption in anaerobiosis and points to a role for oxygen in intestinal dysbiosis. Proposals to evaluate this hypothesis of a role for oxygen in IBD dysbiosis are provided. If this hypothesis is confirmed, decreasing oxygen in the intestine could open novel means to rebalance the microbiota and could provide novel preventative or therapeutic strategies for IBD patients in whom current treatments are ineffective.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23677008      PMCID: PMC3695303          DOI: 10.1038/ismej.2013.80

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  43 in total

Review 1.  Gut microbiota in health and disease.

Authors:  Inna Sekirov; Shannon L Russell; L Caetano M Antunes; B Brett Finlay
Journal:  Physiol Rev       Date:  2010-07       Impact factor: 37.312

2.  Highlighting new phylogenetic specificities of Crohn's disease microbiota.

Authors:  S Mondot; S Kang; J P Furet; D Aguirre de Carcer; C McSweeney; M Morrison; P Marteau; J Doré; M Leclerc
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

3.  A human gut microbial gene catalogue established by metagenomic sequencing.

Authors:  Junjie Qin; Ruiqiang Li; Jeroen Raes; Manimozhiyan Arumugam; Kristoffer Solvsten Burgdorf; Chaysavanh Manichanh; Trine Nielsen; Nicolas Pons; Florence Levenez; Takuji Yamada; Daniel R Mende; Junhua Li; Junming Xu; Shaochuan Li; Dongfang Li; Jianjun Cao; Bo Wang; Huiqing Liang; Huisong Zheng; Yinlong Xie; Julien Tap; Patricia Lepage; Marcelo Bertalan; Jean-Michel Batto; Torben Hansen; Denis Le Paslier; Allan Linneberg; H Bjørn Nielsen; Eric Pelletier; Pierre Renault; Thomas Sicheritz-Ponten; Keith Turner; Hongmei Zhu; Chang Yu; Shengting Li; Min Jian; Yan Zhou; Yingrui Li; Xiuqing Zhang; Songgang Li; Nan Qin; Huanming Yang; Jian Wang; Søren Brunak; Joel Doré; Francisco Guarner; Karsten Kristiansen; Oluf Pedersen; Julian Parkhill; Jean Weissenbach; Peer Bork; S Dusko Ehrlich; Jun Wang
Journal:  Nature       Date:  2010-03-04       Impact factor: 49.962

4.  A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes.

Authors:  Ben P Willing; Johan Dicksved; Jonas Halfvarson; Anders F Andersson; Marianna Lucio; Zongli Zheng; Gunnar Järnerot; Curt Tysk; Janet K Jansson; Lars Engstrand
Journal:  Gastroenterology       Date:  2010-10-08       Impact factor: 22.682

5.  Phosphorescence-assisted microvascular O(2) measurements reveal alterations of oxygen demand in human metastatic colon cancer in the liver of superimmunodeficient NOG mice.

Authors:  Kan Handa; Mitsuyo Ohmura; Chiyoko Nishime; Takako Hishiki; Yoshiko Nagahata; Kenji Kawai; Hiroshi Suemizu; Masato Nakamura; Masatoshi Wakui; Yuko Kitagawa; Makoto Suematsu; Kosuke Tsukada
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Low counts of Faecalibacterium prausnitzii in colitis microbiota.

Authors:  H Sokol; P Seksik; J P Furet; O Firmesse; I Nion-Larmurier; L Beaugerie; J Cosnes; G Corthier; P Marteau; J Doré
Journal:  Inflamm Bowel Dis       Date:  2009-08       Impact factor: 5.325

Review 7.  Establishment of the gut microbiota in Western infants.

Authors:  I Adlerberth; A E Wold
Journal:  Acta Paediatr       Date:  2009-02       Impact factor: 2.299

8.  Gut inflammation provides a respiratory electron acceptor for Salmonella.

Authors:  Sebastian E Winter; Parameth Thiennimitr; Maria G Winter; Brian P Butler; Douglas L Huseby; Robert W Crawford; Joseph M Russell; Charles L Bevins; L Garry Adams; Renée M Tsolis; John R Roth; Andreas J Bäumler
Journal:  Nature       Date:  2010-09-23       Impact factor: 49.962

9.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

Authors:  Harry Sokol; Bénédicte Pigneur; Laurie Watterlot; Omar Lakhdari; Luis G Bermúdez-Humarán; Jean-Jacques Gratadoux; Sébastien Blugeon; Chantal Bridonneau; Jean-Pierre Furet; Gérard Corthier; Corinne Grangette; Nadia Vasquez; Philippe Pochart; Germain Trugnan; Ginette Thomas; Hervé M Blottière; Joël Doré; Philippe Marteau; Philippe Seksik; Philippe Langella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

10.  Human gut microbiome adopts an alternative state following small bowel transplantation.

Authors:  Amber L Hartman; Denver M Lough; Dinesh K Barupal; Oliver Fiehn; Thomas Fishbein; Michael Zasloff; Jonathan A Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-17       Impact factor: 11.205

View more
  126 in total

Review 1.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

2.  In vitro investigation of Debaryomyces hansenii strains for potential probiotic properties.

Authors:  Honeylet Sabas Ochangco; Amparo Gamero; Ida M Smith; Jeffrey E Christensen; Lene Jespersen; Nils Arneborg
Journal:  World J Microbiol Biotechnol       Date:  2016-07-18       Impact factor: 3.312

Review 3.  The Microbiome and Osteosarcopenic Obesity in Older Individuals in Long-Term Care Facilities.

Authors:  Julia E Inglis; Jasminka Z Ilich
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

4.  Anoxic Conditions Promote Species-Specific Mutualism between Gut Microbes In Silico.

Authors:  Almut Heinken; Ines Thiele
Journal:  Appl Environ Microbiol       Date:  2015-04-03       Impact factor: 4.792

Review 5.  The microbiome and innate immunity.

Authors:  Christoph A Thaiss; Niv Zmora; Maayan Levy; Eran Elinav
Journal:  Nature       Date:  2016-07-07       Impact factor: 49.962

6.  High-Fat Diet and Antibiotics Cooperatively Impair Mitochondrial Bioenergetics to Trigger Dysbiosis that Exacerbates Pre-inflammatory Bowel Disease.

Authors:  Jee-Yon Lee; Stephanie A Cevallos; Mariana X Byndloss; Connor R Tiffany; Erin E Olsan; Brian P Butler; Briana M Young; Andrew W L Rogers; Henry Nguyen; Kyongchol Kim; Sang-Woon Choi; Eunsoo Bae; Je Hee Lee; Ui-Gi Min; Duk-Chul Lee; Andreas J Bäumler
Journal:  Cell Host Microbe       Date:  2020-07-14       Impact factor: 21.023

7.  Infection and Immunity Welcomes the New Microbiology.

Authors:  Andreas J Bäumler
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

8.  Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.

Authors:  Sandeep A Walujkar; Shreyas V Kumbhare; Nachiket P Marathe; Dhrati V Patangia; Parimal S Lawate; Renu S Bharadwaj; Yogesh S Shouche
Journal:  World J Microbiol Biotechnol       Date:  2018-05-23       Impact factor: 3.312

9.  Microbiota-nourishing Immunity and Its Relevance for Ulcerative Colitis.

Authors:  Mariana X Byndloss; Yael Litvak; Andreas J Bäumler
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

10.  Microbial Respiration and Formate Oxidation as Metabolic Signatures of Inflammation-Associated Dysbiosis.

Authors:  Elizabeth R Hughes; Maria G Winter; Breck A Duerkop; Luisella Spiga; Tatiane Furtado de Carvalho; Wenhan Zhu; Caroline C Gillis; Lisa Büttner; Madeline P Smoot; Cassie L Behrendt; Sara Cherry; Renato L Santos; Lora V Hooper; Sebastian E Winter
Journal:  Cell Host Microbe       Date:  2017-02-08       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.